Dutasteride for Androgenetic Alopecia—Words of Caution

    Robert B. Haber
    New to Dutasteride? There is a guide in the encyclopedia. Read the guide →
    Studysummary This article discusses the FDA approval of dutasteride for benign prostatic hypertrophy and explores its potential role in treating androgenetic alopecia but reports no new clinical findings.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results